Overall verdict
Neutral
3.6/10
1-year performance
-32.85%
Score breakdown
Down 32.9% over 1 year, 70% of the 52-week range.
Strongest: Growth 10.0/10. Weakest: Shareholder return 0.0/10.
5 analysts, target +0.2% vs the price.
Strive, Inc. is a privately owned investment manager. It primarily provides its services to investment companies. The firm is a large advisory firm, an investment adviser to an investment company which provides portfolio management for investment companies. The firm invests in exchange traded funds. The firm conducts in-house research to make its investments. Strive, Inc. was founded in 2022 and is based in Dallas, Texas.
Sector
Health Care
Industry
Health Care Equipment and Supplies
Primary listing
Nasdaq
United States
CEO
Matthew Cole
Founded
2022
Employees
28
Revenue / employee
204 786 USD
Next earnings
November 9, 2026 (estimated)
Institutional holders
- FMR LLC9.74%
- BlackRock, Inc.5.19%
- Capital International Investors2.97%
- VANGUARD CAPITAL MANAGEMENT LLC2.71%
- GOLDMAN SACHS GROUP INC2.06%
- GEODE CAPITAL MANAGEMENT, LLC1.81%
- STATE STREET CORP1.48%
- MORGAN STANLEY1.40%
- SUSQUEHANNA INTERNATIONAL GROUP, LLP1.21%
- Other institutions10.91%
- Rest of the register60.51%
166 13F filings as of June 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
36.80 USD
52-week low
7.02 USD
1-year performance
-32.85%
Declining
Year-to-date performance
83.11%
Declining
Drawdown
-24.46%
Marked drawdown
Position in the 52-week range
70% of range
Gross margin -10.9%, the company loses 16341.6% of its revenue, ROIC -137.5%, ROE -137.9%.
Net margin
-16341.63%
Negative
Sector 8.67%|S&P 13.13%
Gross margin
-10.89%
Negative
Return on equity (ROE)
-137.87%
Negative
Sector 7.38%|S&P 16.52%
Return on invested capital (ROIC)
-137.53%
Negative
Free cash flow margin (FCF)
-964.26%
Negative
Margin stability
2668.3 pts
Very uneven
Revenue to net income
Growth
10.0/10Revenue down 19.2% over 1 year, 131.1% a year over 5.
Revenue (trailing 12 months)
5.7M USD
Revenue growth (1y)
-19.20%
Declining
Revenue growth (3y)
1571.20%
Hyper-growth
EPS growth (1y)
—
EPS CAGR (5y)
—
EPS revisions (3 months)
—
Valuation
0.0/10The company loses money, so no valuation multiple can be read: a negative P/E is not a discount.
P/E (TTM)
—
N/A (loss)
Sector 28.7x|S&P 23.5x
Forward P/E (adjusted)
—
N/A (loss)
EV / EBITDA
—
N/A (loss)
Sector 15.7x|S&P 14.7x
PEG
—
Sector 0.12|S&P 0.87
Market cap
2.8Md USD
Financial strength
5.8/10Cash covers 5674.0% of the debt, no net debt (net cash).
Net debt / EBITDA
—
Gearing (net debt / equity)
-13.72%
Net cash
Cash
188M USD
Cash / market cap
6.67%
Tight
Cash / total debt
5674.00%
Net cash
Interest coverage
-2913.8x
Stretched
Net debt
-185M USD
Equity
1.3Md USD
Closed daily candles, 2 years
Last close on October 9, 2026: 27.80 USD
- MM2029.12
- MM5022.70
- MM20015.81
- RSI 1453.3
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+6.84%
200-day average slope, 3 months
-11.28%
50-day average slope, 1 month
+45.09%
Price structure
Lower lows
Bullish RSI divergence
No
20-day volatility
2.93 % per day
Volatility change
-44.51%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | -7.64 (2) | -5.83 (2) | 12 (4) | -60 (1) | -538 (3) |
| 2027 | -2.04 (2) | -1.08 (2) | 11 (4) | -58 (1) | -154 (3) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of September 22, 2026.
Same sub-industry: 193 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MDT | 7.0 | 7.1 | 113Md USD | 21.8x | 13.9 % | 13.7 % | 7.0 % | 2.0x | 5.4 % | -9.9 % | ||
| 2 | BSX | 6.9 | 7.4 | 61.9Md USD | 17.3x | 17.5 % | 7.5 % | 10.5 % | 1.8x | 5.9 % | -56.0 % | ||
| 3 | SYK | 6.8 | 7.5 | 106Md USD | 28.7x | 14.4 % | 9.4 % | 10.0 % | 1.7x | 4.4 % | -26.2 % | ||
| 4 | ABT | 6.5 | 6.0 | 172Md USD | 32.2x | 11.6 % | 13.0 % | 7.5 % | 0.5x | 4.5 % | -26.0 % | ||
| 5 | ISRG | 6.4 | 6.8 | 150Md USD | 48.6x | 28.4 % | 18.5 % | 17.4 % | -1.6x | 2.2 % | -5.3 % | ||
| 6 | SHL | 6.4 | 6.4 | 49.0Md USD | 19.8x | 9.6 % | 1.8 % | 7.4 % | 2.7x | 5.2 % | -19.4 % | ||
| 7 | EW | 6.2 | 5.4 | 49.1Md USD | 50.6x | 15.0 % | 13.6 % | 8.7 % | -2.0x | 2.9 % | 12.5 % | ||
| 8 | BDX | 5.3 | 5.0 | 50.1Md USD | 55.4x | 6.2 % | 5.4 % | 3.2 % | 3.4x | 5.1 % | 20.4 % | ||
| 9 | ASST | 3.6 | 2.9 | 2.8Md USD | Not meaningful (loss) | -16341.6 % | -19.2 % | -137.5 % | — | -1.9 % | -32.9 % |
